ONO PHARMACEUTICAL CO., LTD.
4528・Prime Market・Pharmaceuticals
Governance
As a company with a board of company auditors, the board consists of 6 directors (3 of whom are outside directors) and 4 auditors (2 of whom are outside auditors). The company has established the "Executive Personnel Proposal Review Committee" and the "Executive Compensation Proposal Review Committee," both chaired by outside directors, to ensure transparency and objectivity in nomination and compensation matters.
Risk Management
Each risk—including compliance, quality and safety, and information security—is managed by the relevant internal department in accordance with internal regulations. In addition, an Enterprise Risk Management (ERM) framework has been established, under which risks with a significant impact on management are monitored and addressed at a meeting chaired by the Representative Director. Sustainability-related risks have been integrated into ERM, and the Board of Directors provides oversight at a frequency of at least once per quarter.
Shareholder Returns
Under a progressive dividend policy, dividends are paid twice a year with a target payout ratio of 40%. The annual dividend for FY2026 (ending March 2026) is ¥80 per share (interim ¥40 + year-end ¥40), with total dividends of ¥37,929 million and a payout ratio of 53.9%. The annual dividend for FY2027 (ending March 2027) is also forecast at ¥80.
Dividend Policy
A progressive policy to maintain or increase the annual dividend each year. Dividends are paid twice a year (interim and year-end) with a target payout ratio of 40%. The annual dividend for FY2026 (ending March 2026) is ¥80 per share (interim ¥40 + year-end ¥40), with total dividends of ¥37,929 million, and the actual payout ratio (IFRS consolidated) is 53.9%. The forecast annual dividend for FY2027 (ending March 2027) is ¥80 per share (forecast payout ratio of 52.9%). Retained earnings are to be used for R&D, biotech venture partnerships, and the introduction of new drug candidates, among other purposes.
ESG
Under the sustainable management policy formulated in 2021, the company has identified its materiality issues and is advancing initiatives centered on climate change countermeasures (ECO VISION 2050, TCFD response, with carbon neutrality for Scope 1+2 expected to be achieved in 2025) and human capital enhancement (female managers ratio of 9.1%, male childcare leave uptake rate of 88.8%, engagement index of 72), with KPIs set for each area.
Last updated: July 8, 2026